Skip to main content
. 2022 May 17;75(12):2145–2152. doi: 10.1093/cid/ciac332

Table 1.

Characteristics of Participants by Pulmonary Tuberculosis Diagnostic Category

Characteristic Participants, No. (Column %)a
Confirmed Pulmonary Tuberculosis
(n = 90 [30.9%])
Unconfirmed Pulmonary Tuberculosis
(n = 157 [54.0%])
Unlikely Tuberculosis
(n = 44 [15.1%])
Total
(N = 291)
Female sex 42 (46.7) 69 (43.9) 22 (50.0) 133 (45.7)
Age, median (IQR), m 32.4 (13.5–101.6) 31.0 (14.0–68.6) 44.5 (16.9–74.0) 32.0 (14.3–72.6)
Previous tuberculosis treatment 5 (5.6) 13 (8.3) 4 (9.1) 22 (7.6)
Household contact with known tuberculosis case 40 (44.4) 80 (51.0) 18 (40.9) 138 (47.4)
BCG vaccination 76 (84.4) 149 (94.9) 38 (86.4) 263 (90.4)
TST positive 47 (52.2) 83 (52.9) 10 (22.7) 140 (48.1)
BMIZ, median (IQR) 15.1 (13.8–17.0) 15.5 (14.2–17.0) 15.8 (14.2–17.4) 15.4 (14.1–17.0)
WAZ, median (IQR) −1.52 (−2.52 to −0.54) −1.05 (−2.25 to −0.19) −0.60 (−1.81–0.29) −1.23 (−2.37 to −0.14)
Malnutrition 33 (36.7) 45 (28.7) 9 (20.5) 87 (29.9)
HAZ, median (IQR) −1.74 (−2.85 to −0.81) −1.42 (−2.53 to −0.35) −1.46 (−2.24 to 0.23) −1.44 (−2.63 to −0.38)
Stunting 42 (46.7) 53 (33.8) 13 (29.5) 108 (37.1)
HIV positive 15 (16.7) 37 (23.6) 5 (11.4) 57 (19.6)
Receiving ART (% of HIV positive) 15 (100) 28 (75.7) 5 (100) 48 (84.2)
CD4 cell count, median (IQR), cells/mL3 583 (225–833) 799 (181–1192) 321 (95–1135) 631 (174–1025)
Hospitalized 72 (80.0) 119 (75.8) 38 (86.4) 229 (78.7)
No. of tongue swab specimens
 1 25 (27.8) 59 (37.6) 12 (27.3) 96 (33.0)
 2 32 (35.6) 68 (43.3) 10 (22.7) 110 (37.8)
No. of buccal swab specimens
 1 9 (10.0) 9 (5.7) 12 (27.3) 30 (10.3)
 2 24 (26.7) 21 (13.4) 10 (22.7) 55 (18.9)

Abbreviations: ART, antiretroviral treatment; BMIZ, body mass index z score; HAZ, height for age z score; HIV, human immunodeficiency virus; IQR, interquartile range; TST, tuberculin skin test; WAZ, weight for age z score.

a

Data represent no. (column %) of participants unless otherwise specified.